Verteporfin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2844 publications
YAP-TEAD-driven CPA4 promotes NF2-deficient meningioma growth.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Light- and X-ray-Activated Liposomes for Controlled Gene Editing and Drug Delivery.
Journal: Journal of visualized experiments : JoVE
Published: August 18, 2026
YAP/TAZ Signaling in Endothelial Cells Mediates the Pathogenesis of Abdominal Aortic Aneurysm Formation.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026
MMRN1 suppresses thyroid cancer progression via activation of the Hippo signaling pathway.
Journal: Endocrine research
Published: July 01, 2026
Sustained Yap/Taz activation promotes aberrant alveolar epithelial cell differentiation and drives persistent fibrotic remodeling.
Journal: JCI insight
Published: June 09, 2026
Photothermal and photo-oxidation mediated release of lipophilic paclitaxel from liposomes: from formulation to in vitro efficacy and molecular dynamics simulations.
Journal: International journal of pharmaceutics
Published: May 07, 2026
Targeting the Hippo/YAP-TAZ pathway increases X-ray sensitivity in chondrosarcoma spheroids and is associated with autophagic disruption.
Journal: Journal of bone oncology
Published: May 05, 2026
Construction of hepatic stellate cells-targeted nanosystem of verteporfin for the effective treatment of liver fibrosis through mechanical signal modulation.
Journal: Nanotechnology
Published: May 01, 2026
Imaging-guided COX-2 inhibition synergizes with photodynamic immunogenic cell death to potentiate checkpoint blockade in colon cancer.
Journal: International journal of pharmaceutics: X
Published: April 29, 2026
In Situ Sonoafterglow Supramolecular Hydrogel From Natural Substrate for Post-Surgical Glioblastoma Treatment.
Journal: Angewandte Chemie (International ed. in English)
Published: April 24, 2026
Last Updated: 09/26/2026